Literature DB >> 28821206

Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study.

Tabitha Cooney1, Adam Lane1, Ute Bartels1, Eric Bouffet1, Stewart Goldman1, Sarah E S Leary1, Nicholas K Foreman1, Roger J Packer1, Alberto Broniscer1, Jane E Minturn1, Chie-Schin Shih1, Murali Chintagumpala1, Tim Hassall1, Nicholas G Gottardo1, Hetal Dholaria1, Lindsey Hoffman1, Brooklyn Chaney1, Joshua Baugh1, Renee Doughman1, James L Leach1, Blaise V Jones1, Maryam Fouladi1, Katherine E Warren1, Michelle Monje1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28821206      PMCID: PMC5570207          DOI: 10.1093/neuonc/nox107

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  6 in total

Review 1.  Brain stem gliomas: therapeutic options at time of recurrence.

Authors:  R J Packer
Journal:  Pediatr Neurosurg       Date:  1996       Impact factor: 1.162

2.  Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis.

Authors:  Ralph Salloum; Mariko DeWire; Adam Lane; Stewart Goldman; Trent Hummel; Lionel Chow; Lili Miles; Mary Sutton; Charles Stevenson; Maryam Fouladi; James Leach
Journal:  J Neurooncol       Date:  2014-11-30       Impact factor: 4.130

3.  Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience.

Authors:  Johannes E Wolff; Michael E Rytting; Tribhawan S Vats; Peter E Zage; Joann L Ater; Shiao Woo; John Kuttesch; Leena Ketonen; Anita Mahajan
Journal:  J Neurooncol       Date:  2011-08-20       Impact factor: 4.130

4.  Diffuse intrinsic pontine glioma in children and adolescents: a single-center experience.

Authors:  Stefano Gabriele Vallero; Daniele Bertin; Maria Eleonora Basso; Laura Stefania Pittana; Anna Mussano; Franca Fagioli
Journal:  Childs Nerv Syst       Date:  2014-01-14       Impact factor: 1.475

5.  Brain stem tumors in children and adolescents: single institutional experience.

Authors:  Magda Garzón; Gemma García-Fructuoso; Antonio Guillén; Mariona Suñol; Jaume Mora; Ofelia Cruz
Journal:  Childs Nerv Syst       Date:  2013-05-12       Impact factor: 1.475

6.  The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.

Authors:  Joshua Baugh; Ute Bartels; James Leach; Blaise Jones; Brooklyn Chaney; Katherine E Warren; Jenavieve Kirkendall; Renee Doughman; Cynthia Hawkins; Lili Miles; Christine Fuller; Tim Hassall; Eric Bouffet; Adam Lane; Darren Hargrave; Jacques Grill; Lindsey M Hoffman; Chris Jones; Alex Towbin; Sharon A Savage; Michelle Monje; Xiao-Nan Li; David S Ziegler; Sophie Veldhuijzen van Zanten; Christof M Kramm; Dannis G van Vuurden; Maryam Fouladi
Journal:  J Neurooncol       Date:  2017-01-16       Impact factor: 4.130

  6 in total
  28 in total

1.  Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.

Authors:  Erin E Crotty; Sarah E S Leary; J Russell Geyer; James M Olson; Nathan E Millard; Aimee A Sato; Ralph P Ermoian; Bonnie L Cole; Christina M Lockwood; Vera A Paulson; Samuel R Browd; Richard G Ellenbogen; Jason S Hauptman; Amy Lee; Jeffrey G Ojemann; Nicholas A Vitanza
Journal:  J Neurooncol       Date:  2020-06-16       Impact factor: 4.130

Review 2.  Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets.

Authors:  Razina Aziz-Bose; Michelle Monje
Journal:  Curr Opin Oncol       Date:  2019-11       Impact factor: 3.645

3.  Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.

Authors:  Christopher L Tinkle; Kristen Campbell; Yuanyuan Han; Yimei Li; Brandon Bianski; Alberto Broniscer; Raja B Khan; Thomas E Merchant
Journal:  J Neurooncol       Date:  2020-02-03       Impact factor: 4.130

4.  Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.

Authors:  Grant L Lin; Kelli M Wilson; Michele Ceribelli; Benjamin Z Stanton; Pamelyn J Woo; Sara Kreimer; Elizabeth Y Qin; Xiaohu Zhang; James Lennon; Surya Nagaraja; Patrick J Morris; Michael Quezada; Shawn M Gillespie; Damien Y Duveau; Aleksandra M Michalowski; Paul Shinn; Rajarshi Guha; Marc Ferrer; Carleen Klumpp-Thomas; Sam Michael; Crystal McKnight; Paras Minhas; Zina Itkin; Eric H Raabe; Lu Chen; Reem Ghanem; Anna C Geraghty; Lijun Ni; Katrin I Andreasson; Nicholas A Vitanza; Katherine E Warren; Craig J Thomas; Michelle Monje
Journal:  Sci Transl Med       Date:  2019-11-20       Impact factor: 17.956

5.  Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.

Authors:  Nicholas A Vitanza; Matt C Biery; Carrie Myers; Eric Ferguson; Ye Zheng; Emily J Girard; Justyna M Przystal; Giulia Park; Alyssa Noll; Fiona Pakiam; Conrad A Winter; Shelli M Morris; Jay Sarthy; Bonnie L Cole; Sarah E S Leary; Courtney Crane; Nicole A P Lieberman; Sabine Mueller; Javad Nazarian; Raphael Gottardo; Mi-Youn Brusniak; Andrew J Mhyre; James M Olson
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

6.  Causes of death in pediatric neuro-oncology: the sickkids experience from 2000 to 2017.

Authors:  Samuele Renzi; Orli Michaeli; Vijay Ramaswamy; Annie Huang; Derek Stephens; Bryan Maguire; Uri Tabori; Eric Bouffet; Ute Bartels
Journal:  J Neurooncol       Date:  2020-08-14       Impact factor: 4.130

Review 7.  Immune profiling of pediatric solid tumors.

Authors:  Rachael L Terry; Deborah Meyran; David S Ziegler; Michelle Haber; Paul G Ekert; Joseph A Trapani; Paul J Neeson
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

8.  Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.

Authors:  Nicole A P Lieberman; Kole DeGolier; Heather M Kovar; Amira Davis; Virginia Hoglund; Jeffrey Stevens; Conrad Winter; Gail Deutsch; Scott N Furlan; Nicholas A Vitanza; Sarah E S Leary; Courtney A Crane
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

Review 9.  Mechanisms of imipridones in targeting mitochondrial metabolism in cancer cells.

Authors:  Erin R Bonner; Sebastian M Waszak; Michael A Grotzer; Sabine Mueller; Javad Nazarian
Journal:  Neuro Oncol       Date:  2021-04-12       Impact factor: 12.300

10.  Stemming the growth of pediatric gliomas through histone modification.

Authors:  Daniel W Fults
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.